EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma

Maisha F Jabeen iD, Nicholas D Sanderson iD, Mariaenrica Tinè iD, Gillian Donachie iD, Clair Barber iD, Adnan Azim iD, Laurie C K Lau iD, Thomas Brown iD, Ian D Pavord iD, Anoop Chauhan iD, Paul Klenerman iD, Teresa L Street iD und 3 weitere

Allergy · 2024-11 · 79 (11) · 2966-2980

DOI: 10.1111/all.16269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 11.08.2024. Verfasst von Maisha F Jabeen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, Experimental Medicine Division, Respiratory Medicine Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Asthma, Metagenomics, Proteomics, Microbiota. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, National Institute for Health Research Southampton Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The airway microbiome in severe asthma has not been characterised at species‐level by metagenomic sequencing, nor have the relationships between specific species and mucosal immune responses in ‘type‐2 low’, neutrophilic asthma been defined. We performed an integrated species‐level metagenomic data with inflammatory mediators to characterise prevalence of dominant potentially pathogenic organisms and host immune responses.

Methods

Sputum and nasal lavage samples were analysed using long‐read metagenomic sequencing with Nanopore and qPCR in two cross‐sectional adult severe asthma cohorts, Wessex ( n = 66) and Oxford ( n = 30). We integrated species‐level data with clinical parameters and 39 selected airway proteins measured by immunoassay and O‐link.

Results

The sputum microbiome in health and mild asthma displayed comparable microbial diversity. By contrast, 23% (19/81) of severe asthma microbiomes were dominated by a single respiratory pathogen, namely H. influenzae ( n = 10), M. catarrhalis ( n = 4), S. pneumoniae ( n = 4) and P. aeruginosa ( n = 1). Neutrophilic asthma was associated with H. influenzae, M. catarrhalis, S. pneumoniae and T. whipplei with elevated type‐1 cytokines and proteases; eosinophilic asthma with higher M. catarrhalis , but lower H. influenzae , and S. pneumoniae abundance. H. influenzae load correlated with Eosinophil Cationic Protein, elastase and IL‐10. R. mucilaginosa associated positively with IL‐6 and negatively with FGF. Bayesian network analysis also revealed close and distinct relationships of H. influenzae and M. catarrhalis with type‐1 airway inflammation. The microbiomes and cytokine milieu were distinct between upper and lower airways.

Conclusions

This species‐level integrated analysis reveals central, but distinct associations between potentially pathogenic bacteria and airways inflammation in severe asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaMetagenomicsProteomicsMicrobiotaHumansFemaleMaleAdultMiddle AgedSputumMetagenomeCross-Sectional StudiesSeverity of Illness IndexCytokines

Stichwörter der Autor:innen

Asthmabacteriacytokinemicrobiomesputum

Substanzen

Cytokines

Autor:innen und Institutionen

  • Nuffield Department of Medicine, Experimental Medicine Division, Respiratory Medicine Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
  • Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
  • Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories and NIHR Southampton Respiratory Biomedical Research Unit, Southampton University, Southampton, UK.
  • Portsmouth Hospitals NHS Trust, Portsmouth, UK.

ORCID-Profile: Maisha F Jabeen, Nicholas D Sanderson, Mariaenrica Tinè, Gillian Donachie, Clair Barber, Adnan Azim, Laurie C K Lau, Thomas Brown, Ian D Pavord, Anoop Chauhan, Paul Klenerman, Teresa L Street, Emanuele Marchi, Peter H Howarth, Timothy S C Hinks

Förderung

  • Medical Research Council
  • Wellcome Trust
  • National Institute for Health Research Southampton Biomedical Research Centre
  • NIHR Oxford Biomedical Research Centre
  • NIHR Primary Care Research Network

Zitieren

APA

Jabeen, M. F., Sanderson, N. D., Tinè, M., Donachie, G., Barber, C., Azim, A., Lau, L. C. K., Brown, T., Pavord, I. D., Chauhan, A., Klenerman, P., Street, T. L., Marchi, E., Howarth, P. H., & Hinks, T. S. C. (2024). Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma. Allergy, 79(11), 2966-2980. https://doi.org/10.1111/all.16269

Vancouver

Jabeen MF, Sanderson ND, Tinè M, Donachie G, Barber C, Azim A, et al. Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma. Allergy. 2024;79(11):2966-2980. doi:10.1111/all.16269

BibTeX
@article{Jabeen2024,
  author = {Jabeen, Maisha F and Sanderson, Nicholas D and Tinè, Mariaenrica and Donachie, Gillian and Barber, Clair and Azim, Adnan and Lau, Laurie C K and Brown, Thomas and Pavord, Ian D and Chauhan, Anoop and Klenerman, Paul and Street, Teresa L and Marchi, Emanuele and Howarth, Peter H and Hinks, Timothy S C},
  title = {Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {11},
  pages = {2966--2980},
  doi = {10.1111/all.16269}
}
Kostenlos starten →